Orgenesis India Biotech Pvt Ltd to Drive Cell & Gene Therapy Manufacturing

Location: Bengaluru, India –

Adrithi Holdings announced that its 100% subsidiary, Orgenesis India Biotech Pvt Ltd, will spearhead the establishment of India-focused Cell & Gene Therapy (CGT) manufacturing hubs. The initiative will be executed in collaboration with leading Indian hospital chains including Apollo, Fortis, and Manipal.

“Our vision is to make advanced therapies accessible to Indian patients by building a strong manufacturing and hospital-integrated ecosystem,” said Dr. Santhosh Nagaraj.

This marks a pivotal step in democratizing regenerative medicine and positioning India as a hub for CGT innovation.